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renal water conservation and thirst, leading to increased 
water intake, which lowers the sodium concentration 
back towards the normal range. Thus, hypernatraemia 
primarily occurs in those patients who are unable to 
sense thirst or respond to thirst normally by gaining 
access to water [2,3]. 
The diagnostic work-up of a hypernatraemic patient 
usually includes the assessment of extracellular fluid 
(ECF) volume, and measurement of urine osmolality and 
electrolytes. Figure 1 is an example of a diagnostic 
algorithm. Such algorithms should form the basis of 
standard protocols for the diagnostic workup and treat-
ment of affected patients.
 
AbStrAct
Background: Hypernatraemia is a common electrolyte problem in hospitalized patients and is associated with a high 
mortality rate. We determined the incidence, causes, management, and outcomes of hypernatraemia in adult 
hospitalized patients at a large South African tertiary hospital. 
Methods: A retrospective study was conducted at Tygerberg Hospital in Cape Town, South Africa. Adult patients 
with hypernatraemia (at least one serum sodium concentration ≥150 mmol/L) during a 3-month period in 2014 
were identified from our laboratory database for inclusion.
Results: There were 204 patients with hypernatraemia, a prevalence of 1.5%. Of these patients, 101 (49.5%) were 
male, and the mean age was 53 years. There were 66 patients (32.4%) who had hypernatraemia on admission, and 
138 who developed it during the course of their stay in hospital. The overall in-hospital mortality was 38.7%, with 
higher rates for older patients and those with more severe degrees of hypernatraemia. Contributory causes which 
were most commonly present included dehydration/hypovolaemia (45%), followed by sepsis (39%). Net sodium 
gain, rather than water deficit, was identified as the main mechanism in most of the patients who developed hyper-
natraemia in the intensive care units. We found little evidence of any diagnostic work-up and also found that the 
details of fluid therapy and intake–output charting were poorly documented.
Conclusions: There is a very high mortality rate in our hospitalized patients with hypernatraemia.  The diagnostic 
work-up and therapy were often inadequate or poorly documented. The management of this important condition 
needs to be improved with the aid of standardized protocols.
Keywords: hypernatraemia; tonicity balance; South Africa.
INtrODUctION
Hypernatraemia is defined as a rise in serum sodium 
concentration ([Na+]) to a value exceeding 145 mmol/L 
[1]. It is a hyperosmolar condition caused by a decrease 
in total body water relative to sodium content and is best 
thought of as a problem of water homeostasis, rather 
than a “sodium problem”. The high osmolality is asso-
ciated with shrinking in cell volume and the potential 
dangers for affected patients therefore relate to brain cell 
shrinkage [1]. Confusion, seizures or coma may result. 
Subcortical or subarachnoid haemorrhage, and venous 
thrombosis have been described in patients who died of 
severe hypernatraemia [2].
In healthy individuals, water loss seldom leads to hyper-
natraemia because the increase in osmolality stimulates 
African Journal of Nephrology 
Official publication of the African Association of Nephrology 
Volume 22, No 1, 2019, 12-16
A
fr
ic
an
 Jo
ur
na
l o
f N
ep
hr
ol
og
y 
  I
   
Vo
lu
m
e 
22
, N
o 
1,
 2
01
9
13
In patients with hypernatraemia on admission to hospital, a 
large water deficit is usually the basis of the hypernatraemia, 
and replacement of water is the mainstay of treatment. 
However, when hypernatraemia develops during a hospital 
admission, sodium gain is often a major contributor to the 
condition, and the treatment therefore includes creating a 
negative balance for sodium. Acute hypernatraemia can be 
corrected rapidly; however, hypernatraemia that is chronic 
should be corrected at a rate no faster than 8 mmol/L/day 
to avoid cerebral oedema [1].
Hypernatraemia is a common clinical problem in hospitalized 
patients, with the prevalence ranging between 0.5% and 
2%.  In critically ill patients treated in an intensive care unit 
(ICU), the prevalence ranges from 2–6% on admission to 
the ICU. Several studies have reported an association 
between hypernatraemia and in-hospital mortality. 
A Canadian study of 8142 critically ill adult patients identi-
fied ICU-acquired hypernatraemia in 26% [4]. The mor-
tality rate was 34%, as compared to 16% in patients with 
normal sodium concentrations. In the United States, the 
overall prevalence of hospitalized patients with hyper-
natraemia ranges from 0.3–5.5%. Most cases are hospital-
acquired and the proportion of patients who have 
hypernatraemia on admission is estimated at 0.12–1.4%. 
A considerably higher prevalence of 9–26% is seen in 
critically ill patients [5]. A single-centre study from Europe, 
which included 981 patients, found a 9% incidence of 
hypernatraemia in the ICU, with 23% having hypernatraemia 
on admission to the ICU [6].
There are very few data on hypernatraemia in hospitalized 
patients from the developing world, and from Africa in 
particular. We identified only one African study, published 
in 1999, which reported on hypernatraemia at the Mthatha 
General Hospital in the Eastern Cape province of South 
Africa [7]. The study included 98 patients with hyper-
natraemia and reported a prevalence of 1.4% and an overall 
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Step 1: Assess ECF volume and body weight
Step 2: Check urine volume & osmolality
Step 2b: Is U osm very low?
Step 3b: Response to vasopressin
Figure 1.  A diagnostic approach to hypernatraemia.
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mortality of 56%. Hospital-acquired hypernatraemia was 
more frequently observed than hypernatraemia on admis-
sion (59% versus 41%). 
The present study adds to the sparse data on hypernatraemia 
in African settings by reporting on the causes, management 
and outcomes of hypernatraemia in hospitalized patients at 
a large tertiary hospital in Cape Town, South Africa.
MEtHODS
A retrospective, descriptive study was conducted at 
Tygerberg Hospital (TBH), a 1380-bed teaching hospital in 
Cape Town. TBH provides secondary and tertiary level 
care to approximately 1.5 million people in the Western 
Cape province. Laboratory services are provided by the 
National Health Laboratory Service (NHLS).
Adult patients with hypernatraemia ([Na+] ≥150 mmol/L) 
were identified from the NHLS database for a 3-month 
period (July–September 2014). Patient records were 
examined and a standardized data capture sheet used to 
extract information on demographics, clinical diagnosis, 
comorbidities, treatment and outcomes.
During the period of the study, serum sodium and other 
electrolyte concentrations were measured on a Siemens 
ADVIA 1800 Clinical Chemistry Analyzer, which uses an 
ion-selective electrode. At high sodium concentrations, the 
within-run coefficient of variation (CV) was 0.8% and the 
total CV was 1.1%.
Descriptive analysis was reported as means ± standard 
deviations and proportions. Chi-squared and Fisher’s exact 
tests were used to compare proportions. Statistical 
significance was set at p < 0.05.
Ethics approval for the study was granted by the Health 
Research Ethics Committee of Stellenbosch University 
(reference number S17/01/007).
rESULtS 
There were 204 patients with hypernatraemia out of 
13 342 total admissions during the study period, yielding a 
prevalence of 1.5%. Of the hypernatraemic patients, 101 
(49.5%) were male. The mean age was 53 ± 19 years 
(range 18–91 years). 
There were 66 patients (32.4%) who had hypernatraemia 
on admission, and 138 who developed the condition during 
the course of their hospital stay. Of those admitted with 
hypernatraemia, there were 10 (15%) whose hyper-
natraemia worsened after admission. 
The patients were approximately evenly distributed 
between the medical (98 patients, 48%) and surgical wards 
(52%) (Table 1). The mean duration of their hospital stay 
was 15 ± 16 days and the median duration was 9 days 
(interquartile range 5–19 days).
There were 49 patients who were admitted to our medical 
and surgical ICUs, 9 of whom (18%) were admitted with 
hypernatraemia whereas 40 patients (82%) developed it 
during their stay in hospital. Of these 40 patients, 7 had a 
negative fluid balance and only 4 had water deficits sufficient 
to account for at least 50% of the rise in sodium con-
centration.
The most common contributory causes of hypernatraemia 
that were documented were dehydration/hypovolaemia 
(45%) and sepsis (39%) (Table 2).
Regarding complications or symptoms which could be 
related to hypernatraemia, 37 patients had confusion, 18 
had seizures and 20 suffered loss of consciousness. Only 
25 patients (33%) had clearly documented neurological 
improvement after treatment (Table 3).
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table 1.  Distribution of patients with hypernatraemia 
by ward.
Ward n=204 Adm. %*
Medical ward 86 (42%) 42
Medical ICU 12 (6%) 17
Surgical ward 69 (34%) 30
Surgical ICU 37 (18%) 19
*Adm. %: Percentage of patients with hypernatraemia present on admission.
Peak [Na+] ranged from 150–185 mmol/L, with a mean of 155 ± 6 mmol/L.  
The mean peak [Na+] for patients who were admitted with hypernatraemia was  
154 ± 6 vs. 155 ± 5 mmol/L for those who developed hypernatraemia during 
the course of their hospital stay. 
table 2.  Contributory causes of hypernatraemia.
Cause n %*
Dehydration/hypovolaemia           92 (45)
Sepsis                                     79 (39)
Renal failure                            55 (27)
DM/DKA**                                  54 (26)
GIT                                         41 (20)
Diuretic use                             38 (19)
Head injuries                             17 (8)                                             
Burns                                        11 (5)
Malignancy                                  8 (4)
Epilepsy                                      7 (3)
*More than half the patients had more than one contributory cause of 
hypernatraemia; these patients are counted more than once. ** DM/DKA: 
uncontrolled diabetes, including diabetic ketoacidosis.
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There was little documentation regarding diagnostic work-
up, and only five of the 204 hypernatraemic patients had 
samples sent to the laboratory for measurement of urine 
sodium or osmolality.
Unfortunately, there was also poor documentation of 
the management of the hypernatraemia, especially in the 
general medical and surgical wards. The available records 
indicated that most of the patients received 0.9% saline, 
and 62 patients were prescribed tap water and/or 5% 
dextrose water. 
The overall mortality was 38.7%, with a somewhat higher 
unadjusted mortality rate for those patients who had 
developed hypernatraemia during their hospital stay than 
for those admitted with hypernatraemia. This difference 
was not statistically significant (42% vs. 31.8%, p = 0.213). 
There was also no difference in mortality between patients 
with documented neurological symptoms and those 
without (37% vs. 49%, p = 0.189). The unadjusted mortality 
rate was lower in patients whose hypernatraemia resolved 
on treatment (29% vs. 49%, p = 0.004) and highest for 
patients with sodium concentrations above 160 mmol/L 
(75% mortality, Table 4).
On adjusted (multivariate) analysis, there was an inde-
pendent association of death with age and the severity of 
the hypernatraemia (Table 6).
DIScUSSION 
Our study revealed a prevalence of hypernatraemia of 
1.5%, a figure similar to the Mthatha study from the Eastern 
Cape [7]. One-third of our patients had neurological signs 
or symptoms, much higher than in previous studies [5]. 
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table 3.  Complications of hypernatraemia.
Neurological manifestation n*
Confusion           37 (18%)
Seizure                                     18 (9%)
Loss of consciousness                                      20 (10%)
*Patients may be counted more than once.
table 4.  Distribution of serum sodium concentration and 
outcomes.
[Na+] (mmol/L) n Died Died %
150–154 137 40 29
155–159 31 15 48
160–164 20 15 75
≥165 16 10 63
table 5. Comparison of patients admitted with hypernatraemia versus those who developed the condition during their hospital stay.
Hypernatraemia on admission Hypernatraemia after admission p-value
Number 66 (32.4%) 138 (67.6%)
Age (years) 53.6 ± 20 52.8 ± 19 0.966
Duration of hospital stay (days) 6 (2–11) 13 (6–21) <0.001
Hypernatraemia normalized 35 (53%) 61 (44%) 0.291
Mortality 31.8% 42.0% 0.213
Peak [Na+] 154.4 ± 6.3 154.8 ± 5.3 0.923
Neurological complications 24 (36%) 42 (30%) 0.484
table 6.  Multiple logistic regression analysis of baseline risk factors associated with in-hospital mortality in patients with hypernatraemia.
Characteristic Odds ratio (95% CI) p-value
Age 1.02 1.00–1.03 0.031
Peak Na+ concentration 1.11 1.05–1.18 <0.001
Neurological symptoms 0.63 0.29–1.37 0.246
Admission hypernatraemia 0.55 0.28–1.08 0.085
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Our overall mortality rate was 38.7%, considerably lower 
than the Mthatha study and other studies from the 
developed world [5,7]. The age of our patients was similar 
to the Mthatha study but lower than that reported in most 
developed-world studies; this would be expected to 
influence mortality rates [4].
The mortality rate was highest for older patients and those 
with higher sodium concentrations, as has been reported 
previously [5], and there was a higher mortality rate in 
those patients where serum sodium concentrations did not 
normalize with treatment. The most common factors that 
may have contributed to the hypernatraemia were dehy-
dration/hypovolaemia, sepsis and renal failure. More than 
half the patients had more than one potential cause of 
hypernatraemia. These findings are similar to those of the 
Mthatha study.
Most of our patients were being managed in the general 
medical and surgical wards. Other studies have reported a 
greater proportion of hypernatraemic patients being 
managed in an ICU setting [4-6]. A possible reason for this 
is that there are relatively few beds in our medical and 
surgical ICUs, and critically ill patients are often managed in 
general wards when ICU beds are not available. It is also 
possible that there may be greater awareness of the 
significance of hypernatraemia and its management in our 
ICUs, where more care might be taken to prevent 
hypernatraemia by, for example, more frequent monitoring 
of electrolytes and appropriate adjustments of fluid 
prescription.
Most patients developed hypernatraemia during their stay 
in hospital. There was no difference in mortality rate 
between these patients and those who had hypernatraemia 
on admission. 
To understand the mechanisms underlying the develop-
ment of hypernatraemia, it is useful to perform a tonicity 
balance and consider the contributions of net water deficit 
and/or net sodium gain in each patient [8]. This should 
guide the therapy required and requires accurate charting 
of the intake and output for the period during which the 
hypernatraemia develops. At a minimum, the volumes of 
fluid taken in and excreted need to be known, even if the 
solute content of the fluids is not. If the negative fluid 
balance (net water loss) is not sufficient to explain the rise 
in [Na+], then sodium gain can be inferred. Our study 
included 40 ICU patients with good documentation of 
input and output. Of these, 33 had positive fluid balances, 
3 had small negative fluid balances and only 4 had large 
negative fluid balances sufficient to explain at least 50% of 
the rise in Na+. Sodium gain was therefore the main 
mechanism in at least 90% of these ICU cases. Similar 
findings have been reported previously [9,10].
An important finding from our study was the almost com-
plete absence of clearly documented diagnostic work-ups 
for hypernatraemia. In addition, there was documented 
prescription of hypotonic fluid or tap water in less than half 
of the cases. This suggests a lack of appreciation of the 
importance of hypernatraemia and/or lack of knowledge 
regarding its diagnostic work-up and management. 
Our study has several limitations. In particular, the available 
documentation was poor in many cases. This included 
incomplete information on fluid input and output volumes, 
as well as the type of fluid administered. The documentation 
was better in the ICUs than in the general wards. 
cONcLUSION 
Hypernatraemia has significant associated mortality and 
should be a priority for early recognition and treatment in 
hospitalized patients. The diagnostic work-up and manage-
ment need to be improved with the aid of standardized 
protocols. Appropriate laboratory studies should include 
the measurement of urine electrolyte concentrations and 
osmolality. Good documentation of the diagnostic work-
up, fluid prescription, and input and output volumes is 
essential. 
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